Dissecting active ingredients of Chinese medicine by content-weighted ingredient-target network.
暂无分享,去创建一个
Xiang Li | Zheng Li | Ni Ai | Qing Shao | Xiaohui Fan | Linli Wang | Xiaoping Zhao | Xiaoping Zhao | Ni Ai | Xiaohui Fan | Zheng Li | Lin-li Wang | Xiang Li | Qing Shao
[1] F. Cheung. TCM: Made in China , 2011, Nature.
[2] Xue Xu,et al. A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.
[3] Jong-Hoon Kim,et al. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach , 2013, Journal of ginseng research.
[4] Peter J. Tonellato,et al. Rat Genome Database (RGD): mapping disease onto the genome , 2002, Nucleic Acids Res..
[5] Andrew Jenner,et al. Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines. , 2004, Free radical biology & medicine.
[6] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[7] A. Barabasi,et al. Lethality and centrality in protein networks , 2001, Nature.
[8] Alan L Harvey,et al. Natural products in drug discovery. , 2008, Drug discovery today.
[9] Kai Huang,et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..
[10] Yi Wang,et al. A Network Pharmacology Approach to Evaluating the Efficacy of Chinese Medicine Using Genome-Wide Transcriptional Expression Data , 2013, Evidence-based complementary and alternative medicine : eCAM.
[11] Melinda R. Dwinell,et al. The Rat Genome Database 2013—data, tools and users , 2013, Briefings Bioinform..
[12] Qing Shao,et al. Chemical fingerprinting and quantitative analysis of a Panax notoginseng preparation using HPLC-UV and HPLC-MS , 2011, Chinese medicine.
[13] S. L. Wong,et al. Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.
[14] Jun Xu,et al. Chinese herbal medicine and acupuncture for the treatment of cardiovascular disease , 2009 .
[15] Zhi Wang,et al. Ginsenoside Rb1 Preconditioning Protects Against Myocardial Infarction After Regional Ischemia and Reperfusion by Activation of Phosphatidylinositol-3-kinase Signal Transduction , 2008, Cardiovascular Drugs and Therapy.
[16] Xiaowei Xu,et al. Constructing a robust protein-protein interaction network by integrating multiple public databases , 2011, BMC Bioinformatics.
[17] D. K. Arrell,et al. Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.
[18] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[19] R. Bauer,et al. Phytochemistry and pharmacogenomics of natural products derived from traditional chinese medicine and chinese materia medica with activity against tumor cells , 2008, Molecular Cancer Therapeutics.
[20] Yan Yu-zhen,et al. Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction , 2005 .
[21] Feng Gao,et al. Ginsenoside Rd Attenuates Myocardial Ischemia/Reperfusion Injury via Akt/GSK-3β Signaling and Inhibition of the Mitochondria-Dependent Apoptotic Pathway , 2013, PloS one.
[22] Y. Tu. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine , 2011, Nature Medicine.
[23] Zhi-xiang Shen,et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.
[24] Yong Jiang,et al. Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats. , 2013, Journal of Ethnopharmacology.
[25] Noel M. O'Boyle,et al. De novo design of molecular wires with optimal properties for solar energy conversion , 2011, J. Cheminformatics.
[26] Chenguang Zhang,et al. Spirituality in Traditional Chinese Medicine , 2012 .
[27] Wei Liu,et al. A Network Study of Chinese Medicine Xuesaitong Injection to Elucidate a Complex Mode of Action with Multicompound, Multitarget, and Multipathway , 2013, Evidence-based complementary and alternative medicine : eCAM.
[28] E. Braunwald,et al. A tale of coronary artery disease and myocardial infarction. , 2012, The New England journal of medicine.
[29] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[30] Calvin Yu-Chian Chen,et al. TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.
[31] D. Kremastinos,et al. Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits. , 2000, Atherosclerosis.
[32] Fulong Liao,et al. Chinese medicine, flowing blood, biomechanopharmacology and future preventive medicine , 2012 .
[33] Tiejun Cheng,et al. Characterizing protein domain associations by Small-molecule ligand binding. , 2012, Journal of proteome science and computational biology.
[34] Axel Drefahl,et al. CurlySMILES: a chemical language to customize and annotate encodings of molecular and nanodevice structures , 2011, J. Cheminformatics.